Incyte Corporation Price Today
Incyte Corporation
INCY
Healthcare
$14.20B
💰
Market Cap
44.5
💸
Price to Earnings
$1.4
🎉
EPS
+0
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
9 |
Strong Buy |
6 |
Hold |
12 |
Sell |
0 |
Strong Sell |
0 |
INCY Price Forecast Target
63.6 👉 114.0 +79%
INCY EPS Forecast
1.4 👉 4.6 +221%
Financials
Profit Margin
10 %
Revenue Growth
4.7 %
Dividend
$ 0
Held Percent
1.4% - Insiders
99.4% - Institutions
-0.8% - Public
Major Fund Holders
-
💰 Baker Brothers Advisors, LLC $2.6B
-
💰 Vanguard Group Inc $1.6B
-
💰 Blackrock Inc. $1.5B
-
💰 Dodge & Cox Inc $1.4B
-
💰 Royal Bank of Canada $915.5M
Stock Ideas
Howard Marks Portfolio
Meet Howard Marks, the co-founder and lead of Oaktree Capital Management, a Los Angeles-based investment firm that manages roughly $78 billion in investment capital. Marks has an impressive background in distressed debt, high yield bonds, and conver…
Charlie Munger Portfolio
Charlie Munger, the renowned investor and Vice Chairman of Berkshire Hathaway, is a true titan in the world of finance. Often referred to as Warren Buffett's right-hand man, Munger's portfolio investment approach is a masterclass in disciplined and …
David Einhorn Portfolio
David Einhorn is one of the most successful long/short equity hedge fund managers of the past decade. As of July 2013, David Einhorn’s Greenlight Capital has returned 19.5% since its inception in 1996. Greenlight Capital’s market beta is around 0.5,…
Christopher Hohn Portfolio
Christopher Hohn is a British hedge fund manager and philanthropist. He founded The Children's Investment Fund Management in 2003, one of Europe's largest hedge funds. Known for his activist investment approach, Hohn targets undervalued companies wi…📮FAQ
Some Frequently Asked Questions.
The Incyte Corporation industry is Biotechnology
The Incyte Corporation sector is Healthcare
The Incyte Corporation forecasted predicted Price to Earnings PE ratio is 13.9
The Incyte Corporation Price to Earnings PE ratio is 44.5
The Market Capitalization of Incyte Corporation is $14.20B
There are total of 186324437 float shares with 99.4% held by Institutions and 1.4% held by insiders
The MIncyte Corporation forecasted Earnings per Share EPS is $4.6
The Incyte Corporation Earnings per Share EPS is 1.4
The Incyte Corporation company has $1593729000 gross profits with 10 profit margins
The Incyte Corporation Earnings Growth is 0.25% with 0.261% quarterly earnings growth
The Incyte Corporation Revenue is $3513285888 with 0.047 revenue growth
The price target for Incyte Corporation stock is $114.0 for the high target and $65.0 for the low target
The consensus analyst recommendations for Incyte Corporation is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Incyte Corporation is Buy, with the following breakdown:
- Buy: 9
- Strong Buy: 6
- Hold: 12
- Sell: 0
- Strong Sell: 0
The Beta of Incyte Corporation is 0.7
The dividend of Incyte Corporation is $0
The dividend yield of Incyte Corporation is 0%
The biggest institutional and mutual fund holders of Incyte Corporation stock are
- Baker Brothers Advisors, LLC
- Vanguard Group Inc
- Blackrock Inc.
- Dodge & Cox Inc
The Incyte Corporation ESG Score is 0, with the following breakdown:
- E: 0
- S: 0
- G: 0